The Genome Editing/Genome Engineering Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Genome Editing/Genome Engineering Market?
The market size for genome editing/genome engineering has seen a fast-paced rise. It increased from $8.62 billion in 2024 to $10.2 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.2%. The historical growth trend in the Genome Editing/Genome Engineering market has seen it grow rapidly.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Genome Editing/Genome Engineering Industry?
The Genome Editing/Genome Engineering market is projected to reach a size of $20.81 billion in 2029, with a compound annual growth rate (CAGR) of 19.5%.
Download Your Free Sample of the 2025 Genome Editing/Genome Engineering Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Genome Editing/Genome Engineering Market?
The key drivers in the genome editing/genome engineering market are:
• Emergence of prime editing methods
• Focus on ethical and regulatory frameworks in genome editing
• Increasing adoption of genome engineering in drug discovery
• Therapeutic potential for treating genetic disorders
Global Market Segmentation: Identifying Major Genome Editing/Genome Engineering Industry Segments
The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes
Pre-order the 2025 Genome Editing/Genome Engineering Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Genome Editing/Genome Engineering Market?
The key trends in the genome editing/genome engineering market are:
• The emergence of prime editing and new genome editing tools is shaping the future of the market.
• There is increasing focus on ethical and regulatory frameworks related to genome engineering.
• Genome editing is being increasingly adopted in drug discovery and gene function studies.
• The integration of artificial intelligence in genome editing design is an emerging trend.
Who Are the Top Competitors & Leading Players in the Genome Editing/Genome Engineering Market?
Major companies in the genome editing/genome engineering market are:
• Thermo Fisher Scientific Inc.
• Merck Group
• Genscript Biotech Corp
• Sangamo Therapeutics Inc.
• Lonza Group AG
• Editas Medicine Inc.
• CRISPR Therapeutics AG
• Agilent Technologies Inc.
• Intellia Therapeutics
• bluebird bio Inc.
• Transposagen Biopharmaceuticals Inc.
• Tecan Trading AG
• Precision BioSciences
• PerkinElmer Inc.
• Cellectis S.A
• Applied StemCell Inc.
• Bio-Rad Laboratories Inc.
• Bio-Techne
• Creative Biogene
• Cyagen Biosciences
• Dharmacon Inc.
• Eurofins Genomics LLC
• Evotec SE
• GeneCopoeia Inc.
• Genewiz
• Horizon Discovery Group PLC
• Inscripta Inc.
• Integrated DNA Technologies Inc.
• MaxCyte Inc.
• New England Biolabs
• Novartis International AG
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the gene editing/genome engineering market in 2024
